Quantification of Functional MR Predicts Early Response in Post-doxorubicin Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma.

Hsin-You OuYu-Fan ChengYi-Hsuan ChuangHsien-Wen HsuChao-Long ChenMarirose Zingapan LazoChing-Chun WengChun-Yen YuLeo Leung-Chit TsangTung-Liang HuangYu-Shun Tong

Published in: Digestive diseases and sciences (2019)

Combined DWI and MRS may be used as an early imaging biomarker of therapy response in HCC patients after chemoembolization therapy.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
high resolution
radiofrequency ablation
drug delivery
magnetic resonance imaging
stem cells
diffusion weighted imaging
contrast enhanced
cell therapy